PMID: 9539581Apr 16, 1998Paper

Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine

International Journal of Radiation Oncology, Biology, Physics
W S BiceD F Dubois

Abstract

To determine the clinical impact upon permanent interstitial prostate 125I brachytherapy after conversion to AAPM Task Group 43 (TG 43) guidelines. The value of quantities used in the calculation of dose from two institutions, Northwest Tumor Institute (NWTI) and Memorial Sloan-Kettering Cancer Center (MSKCC), which pioneered interstitial techniques for prostate brachytherapy were compared to those recently determined and published by TG 43 of the American Association of Physicists in Medicine (AAPM). Using two different weighting schemes, the change in the commonly prescribed reference dose of 160 Gy was determined and found to be in agreement with that recently suggested. Volumes encompassed by the reference isodose surface were determined from a single source implant and a regularly distributed implant to show the effect of change in reference dose. A comparative analysis on 10 patients was performed to show how this change affected common implant quality descriptors and the effect of changing the calculation formalism without changing the reference dose. Both weighting schemes suggested a change in reference dose from 160 to 144 Gy. Single-source and distributed-source volumetric analysis confirmed this value. The effect on...Continue Reading

References

Jan 1, 1976·Medical Physics·L L Anderson
Jul 11, 1992·Urology·J B Priestly, D C Beyer
Jan 1, 1991·International Journal of Radiation Oncology, Biology, Physics·C B Saw, N Suntharalingam
Sep 30, 1994·International Journal of Radiation Oncology, Biology, Physics·K WallnerL Harrison
Jan 1, 1997·International Journal of Radiation Oncology, Biology, Physics·B R PrestidgeJ C Blasko
Feb 11, 1998·International Journal of Radiation Oncology, Biology, Physics·B R PrestidgeW S Bice

❮ Previous
Next ❯

Citations

Jan 9, 2001·CA: a Cancer Journal for Clinicians·H RagdeA A Elgamal
Jul 4, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F GuedeaM Ventura
Sep 18, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Haim MatzkinMoshe Inbar
Feb 13, 2001·International Journal of Radiation Oncology, Biology, Physics·W S BiceM F Sarosdy
Apr 8, 1998·International Journal of Radiation Oncology, Biology, Physics·J J PreteP D Grimm
May 29, 1999·International Journal of Radiation Oncology, Biology, Physics·F A ViciniA Martinez
Jul 1, 1999·International Journal of Radiation Oncology, Biology, Physics·S NagR Nath
Feb 3, 2000·International Journal of Radiation Oncology, Biology, Physics·S NagY Yu
Dec 24, 1998·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·C B SawR Nath
Feb 4, 2012·Japanese Journal of Radiology·Takeo NomuraHiromitsu Mimata
Sep 14, 2010·International Journal of Radiation Oncology, Biology, Physics·Alfonso Gómez-Iturriaga PiñaClement Ma
Oct 3, 1999·Medical Physics·R E Wallace, J J Fan
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yolanda PardoMontserrat Ferrer
May 3, 2016·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Pedro J PradaJesica Sanchez
Jul 21, 2004·Medical Physics·Dirk FlühsNorbert Bornfeld
Feb 9, 2000·Radiologic Clinics of North America·J L Speight, M Roach
Aug 25, 2004·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Barby Pickett, Jean Pouliot
Dec 2, 1999·Radiation Oncology Investigations·R E PeschelR Nath
Nov 23, 2017·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Pedro J PradaSamuel Ruiz Arrebola
Oct 29, 2004·International Journal of Impotence Research·N MabjeeshH Matzkin
Jan 5, 2000·Seminars in Surgical Oncology·H Ragde, L Korb
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L PottersS Leibel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.